Oxybutynin Powder Cas No.5633-20-5

Oxybutynin Powder Cas No.5633-20-5

Khoom npe: Oxybutynin Powder
Khoom Source: Synthetic
Specification: Ntau dua lossis sib npaug li 98%
CAS Nr .: 5633-20-5
Molecular Formula: C₂₂H₃₁NO₃
Molecular Luj: 357.49 g / mol
Txoj Kev Xeem: HPLC
Cov khoom xyaw nquag: Oxybutynin (Oxybutynin)
Cov yam ntxwv ntawm cov khoom: Dawb rau tawm -dawb khoom los yog crystalline hmoov
Ntim Cov Khoom: 1kg / hnab; 25kg / nruas
Cia Lub Sij Hawm: Khaws rau hauv qhov chaw qhuav, txias, zoo - qhov cua thiab kaw kom nruj
Lub neej txee: 24 lub hlis
Kev Tshaj Tawm Txog Kev Siv: Cov khoom no yog tsim los siv rau kev lag luam lossis kev tshawb fawb tshawb fawb nkaus xwb.
Xa kev nug

Khoom Description

Peb muab siab -purity Oxybutynin API nrog kev ruaj khov purity siab tshaj 98%, nruj me ntsis raws li kws kho mob- cov qauv qib. Siv cov txheej txheem sib xyaw ua ke thiab cov txheej txheem kuaj xyuas meej zoo li HPLC, peb siv cov kev tswj xyuas zoo rau txhua pawg kom ntseeg tau tias cov tshuaj purity zoo ib yam, cov ntsiab lus tsis zoo, thiab cov khoom zoo heev - rau -batch stability.

Cov khoom no nthuav tawm zoo heev solubility hauv dej thiab acids. Peb tshwj xeeb hauv kev muab siab - APIs zoo uas ua tau raws li cov kev cai tswj hwm rau cov tuam txhab tsim qauv. Tsim nyog rau kev txhim kho thiab tsim cov tshuaj rau lub zais zis ntau dhau thiab lwm yam mob, peb tau cog lus los muab cov khoom siv ruaj khov, txhim khu kev qha raw khoom thiab kev txhawb nqa rau peb cov neeg koom tes.

Cov khoom muaj nuj nqi

Cov khoom xyaw nquag oxibunine yog kev sib tw muscarinic acetylcholine receptor antagonist. Nws lub luag haujlwm tseem ceeb yog ua kom muaj zog tiv thaiv kev tsis tuaj yeem cuam tshuam ntawm lub zais zis cov leeg nqaij thaum tseem ua rau cov leeg nqaij ncaj qha mus so. Nws cov txheej txheem tseem ceeb txo qis detrusor overactivity, ua kom lub zais zis muaj peev xwm, thiab ncua sij hawm tso zis tso zis, yog li tswj cov tsos mob ntawm cov zis.

Cov khoom Apdaim ntawv thov

Raws li cov tshuaj nquag siv tshuaj (API), cov khoom no feem ntau yog siv los tsim cov qauv tshuaj kho mob zais zis (OAB), hais txog cov tsos mob hauv qab no:

1). Ceev ceev

2). Ntau zaus

3). Hais kom urinary incontinence

Tsis tas li ntawd, nws yog siv los kho cov zais zis neurogenic tsis ua haujlwm (xws li lub zais zis ntau dhau los ntawm cov xwm txheej zoo li tus txha caj qaum raug mob lossis ntau yam sclerosis).

Mechanism ntawm Akev txiav txim

Oxybutynin exerts nws cov teebmeem los ntawm kev sib tw antagonizing qhov khi ntawm cholinergic neurotransmitter acetylcholine rau M3 receptors (feem ntau nyob rau hauv cov leeg detrusor ntawm lub zais zis). Qhov kev tawm tsam no thaiv cov acetylcholine - ntxias cov leeg nqaij contraction, yog li so cov leeg detrusor. Ntawm qhov siab siab, nws kuj tseem ua haujlwm ncaj qha, tsis yog -atropine- nyob ntawm cov leeg nqaij so los ntawm kev thaiv cov cellular calcium influx.

Pharmacological teebmeem

Txhawb nqa detrusor overactivity: Qhov tseem ceeb txo qhov zaus thiab kev siv ntawm lub zais zis tsis ua haujlwm.

Ua kom lub zais zis muaj peev xwm: Txhim kho cov zis tso zis, txo qhov tso zis ntau zaus.

Kev ncua sij hawm thawj zaug kom tso zis: Ncua lub sijhawm ntawm kev ntuav.

Ua kom lub zais zis siab tshaj plaws: Txhim kho lub zais zis tsis ua haujlwm.

Thaum kawg:Ua tau zoo txo ​​cov tsos mob xws li tso zis ceev, zaus, thiab yaum kom incontinence, txhim kho cov neeg mob lub neej zoo.

 

 

 

 

 

 

 

Cim npe nrov: Tuam Tshoj oxybutynin hmoov cas no.5633-20-5 manufacturers, lwm tus neeg, Hoobkas

Xa kev nug